ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Bortezomib Impacts T-Cell Signaling and Regulatory Pathways

    O. Moussa, M. Askar, H. Gebel, S. Flechner, D. Taber, K. Chavin, P. Baliga, T. Srinivas

    Med. Univ South Carolina, Charleston; Cleveland Clinic, Cleveland; Emory University, Atlanta

    Introduction/ Aims: Bortezomib (PS-341), a selective 26S proteasome inhibitor has been used to treat antibody mediated rejection (AMR) among allograft recipients. The efficacy of Bortezomib…
  • 2013 American Transplant Congress

    Outcomes in Lung Transplantation: The RIFLE Classification Optimizes the Predictive Utility of Post-Transplant Acute Kidney Injury as a Determinant of Early and Late Outcomes

    A. Osho, A. Castleberry, L. Snyder, S. Palmer, S. Lin, R. Davis, M. Hartwig

    Department of Surgery, Duke University Medical Center, Durham, NC; Department of Medicine, Duke University Medical Center, Durham, NC

    The purpose of this study is to compare two methods of classifying acute kidney injury (AKI), the Risk, Injury, Failure, Loss, End stage (RIFLE) and…
  • 2013 American Transplant Congress

    Gene Expression Assessment in Kidney Transplant Biopsies To Predict Outcomes in Antibody-Mediated Rejection

    A. Loupy, J. Reeve, J. Chang, L. Hidalgo, D. Vernerey, G. Hill, C. Legendre, P. Halloran

    Hôpital Necker, Paris, France; University of Alberta, Edmonton, Canada; Paris Cardiovascular Research Centre, Paris, France; Hôpital Européen Georges Pompidou, Paris, France

    Antibody-mediated rejection (ABMR) is a major cause of kidney transplant failure, but the determinants of outcome are poorly defined. We hypothesized that disease activity and…
  • 2013 American Transplant Congress

    Preexisting Donor Specific Antibody (DSA) with a Negative Flow Crossmatch (FCXM) Should Not Preclude Kidney Transplantation

    V. Kumar, V. Hauptfeld-Dolejsek, A. Kamal Abdelkader, J. Goodman, J. Locke, R. Gaston

    University of Alabama at Birmingham, Birmingham

    Background: DSA is associated with increased risk for acute antibody mediated rejection (AMR). The optimal immunosuppression strategy for FCXM negative (-) DSA positive (+) renal…
  • 2013 American Transplant Congress

    Optimization of the Coating of Pancreatic Islets with T Regulatory Cells in the Novel Immunoprotective Approach

    K. Golab, S. Kizilel, T. Bal, M. Hara, M. Zielinski, X. Wang, J. Grzanka, L. Wang, O. Cochet, M. Tibudan, P. Witkowski

    Department of Surgery, University of Chicago, Chicago, IL; Department of Chemical and Biological Engineering, College of Engineering, Koc University, Istanbul, Turkey; Department of Medicine, University of Chicago, Chicago, IL

    Aim. T regulatory cells (Tregs) possess immunosuppressive properties and can serve as an effective therapy in transplantation. Recently, we have shown that Tregs can be…
  • 2013 American Transplant Congress

    Rate and Causality of Thirty-Day Readmissions Following Renal Transplantation

    M. Watson, D. Goldfarb, V. Krishnamurthi, D. Shoskes, J. Rabets

    Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH

    Introduction: The Affordable Care Act, added to the Social Security Act, established the Hospital Readmission Reduction Program which will penalize hospitals with excessive 30-day readmissions…
  • 2013 American Transplant Congress

    Single Center Experience with Long-Term Prospective BK Monitoring in Renal Transplantation

    J. Trofe-Clark, D. Sawinski, T. Sparkes, S. Goral, M. Bleicher, R. Bloom

    Pharmacy, Hospital of Univ of Pennsylvania, Philadelphia; Renal, Perelman School of Medicine, Univ of Pennsylvania, Philadelphia, PA

    Prospective screening for BK viremia (BKV) in renal transplant recipients (RTR) may allow earlier detection of BKV reactivation and prevent BKV nephropathy (BKVN). However, utility…
  • 2013 American Transplant Congress

    Pivotal Circulating Antibody Panel for Pre-Transplant Prediction of FSGS Recurrence after Kidney Transplantation, A

    M. Sarwal, M. Delville, T. Sigdel, C. Wei, A. Fernoni, G. Burke, M. Naesens, A. Jackson, N. Alachkar, G. Canaud, C. Legendre, J. Reiser, D. Anglicheau

    California Pacific Medical Center, San Francisco; Department of Kidney Transplantation, Necker Hospital, Paris, France; Division of Transplant Surgery, University of Miami School of Medicine, Miami; Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium; The Johns Hopkins Incompatible Kidney Transplant Team, John Hopkins, Baltimore

    Introduction: Recurrence of focal segmental glomerulosclerosis (rFSGS) after kidney transplantation leads to graft loss. The identity of the involved antibodies and specific immunogenic epitopes remains…
  • 2013 American Transplant Congress

    Outcome Reporting in Randomised Controlled Trials (RCTs) of Primary Immunosuppression in Kidney Transplantation

    P. Masson, F. Duthie, P. Kelly, G. Higgins, J. Craig, A. Webster

    Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia; Cochrane Renal Group, Centre for Kidney Research, Sydney, NSW, Australia; Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom; Centre for Renal and Transplant Research, Westmead Hospital, Sydney, NSW, Australia

    Aims: To estimate the proportion of contemporary RCTs of primary immunosuppression in kidney transplantation reporting specified patient and graft-related outcomes, objectively measure reporting quality and…
  • 2013 American Transplant Congress

    Regulation of Serological Alloreactive Memory by Pathogen Infection, The

    R. Ruhil, O. Bulut, S. Talebagha, B. Oh, V. Lu, S. Knechtle, N. Iwakoshi

    Emory Transplant Center, Atlanta

    The breadth and strength of HLA specific antibodies (HSA) have a significant impact on waiting times for transplantation and the presence of HSA prior to…
  • « Previous Page
  • 1
  • …
  • 117
  • 118
  • 119
  • 120
  • 121
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences